Deltex Medical Group (DEMG)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.65
  • 52 Week Low: 0.90
  • Currency: UK Pounds
  • Shares Issued: 524.46m
  • Volume: 29,873
  • Market Cap: £7.87m
  • RiskGrade: 450

Deltex Medical wins EU grant for blood monitoring product

By Maryam Cockar

Date: Thursday 27 Apr 2017

LONDON (ShareCast) - (ShareCast News) - Deltex Medical Group, a maker for blood monitoring and fluid management equipment for use in surgical operations, has won a €50,000 grant from the European Union.
The AIM-listed company was awarded the grant from the EU's Horizon 2020 programme which finances feasibility studies for bringing new products on to the market, and it could be followed by up to €2.5m under phase two of Deltex's medical product development.

Deltex, along with Lariboisiere Hospital in Paris, have developed a system which provides simultaneous visual display of a patient's aortic blood flow velocity and aortic blood pressure called called TruVue, which is expected to significantly contribute to patient safety.

The EU funding will help Deltex test the system with users and collect feedback about their experience with the graphical user interface and help work out the price of a multinational clinical trial for phase two.

The €50,000 grant is to be received in the first half of the year and the company will be able to apply for phase two funding as soon as it is able to demonstrate success from the feasibility work.

Deltex chief executive Ewan Phillips said: "We are delighted to receive this endorsement and the potential for the larger phase two award, although there can be no certainty as to if, or when this may come to fruition.

"The phase one grant coincides with our plan to release the Velocity Pressure loop software, developed in partnership with Labroisiere Hospital in Paris, to select clinical experts in the second half of the year for clinical trials."

The software is predicated on the CardioQ-ODM+'s ability to measure continuously central blood flows and arterial blood pressure, which can provide new insight into changes in patients' vascular resistance and compliance.

Shares in Deltex Medical up 4.12% to 4.16p at 0830 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DEMG Market Data

Currency UK Pounds
Share Price 1.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.65
52 Week Low 0.90
Volume 29,873
Shares Issued 524.46m
Market Cap £7.87m
RiskGrade 450

DEMG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Price Trend
62.26% above the market average62.26% above the market average62.26% above the market average62.26% above the market average62.26% above the market average
12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average
Income Not Available
Growth
56.19% below the market average56.19% below the market average56.19% below the market average56.19% below the market average56.19% below the market average
70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DEMG Dividends

No dividends found

Trades for 07-Jul-2020

Time Volume / Share Price
15:10 25,873 @ 1.40p
12:33 4,000 @ 1.40p

DEMG Key Personnel

Chair Nigel J Keen
CEO Andy Mears

Top of Page